methylazoxymethanol acetate has been researched along with phencyclidine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Didriksen, M; Flagstad, P; Leist, M; Michael-Titus, AT; Penschuck, S | 1 |
Esmaeili, B; Grace, AA | 1 |
2 other study(ies) available for methylazoxymethanol acetate and phencyclidine
Article | Year |
---|---|
Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cell Count; Disease Models, Animal; Embryo, Mammalian; Excitatory Amino Acid Antagonists; Female; Gene Expression; Hippocampus; Immunohistochemistry; Methylazoxymethanol Acetate; Motor Activity; Neurons; Parvalbumins; Phencyclidine; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Schizophrenia; Time Factors | 2006 |
Afferent drive of medial prefrontal cortex by hippocampus and amygdala is altered in MAM-treated rats: evidence for interneuron dysfunction.
Topics: Action Potentials; Amygdala; Animals; Electric Stimulation; Excitatory Amino Acid Antagonists; Hippocampus; Interneurons; Male; Methylazoxymethanol Acetate; Neural Inhibition; Neural Pathways; Neurotoxins; Phencyclidine; Prefrontal Cortex; Rats; Schizophrenia | 2013 |